Ciliary neurotrophic factor and interleukin-6 differentially activate microglia

Journal of Neuroscience Research

Volumn 86, Issue 7, 2008, Pages 1538-1547

  Krady, J Kyle ^a   Lin, Hsiao Wen ^b   Liberto, Christina M ^a   Basu, Anirban ^c   Kremlev, Sergey G ^a   Levison, Steven W ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c National Brain Research Center   (India)

Author keywords

COX 2; GDNF; IL 6; Inflammation; Neurodegeneration; TNF

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CYCLOOXYGENASE 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; EMBRYO; ENZYME PHOSPHORYLATION; GENE EXPRESSION; MACROPHAGE ACTIVATION; MICROGLIA; MOTONEURON; NERVE CELL CULTURE; NERVE CELL STIMULATION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CEREBRAL CORTEX; CILIARY NEUROTROPHIC FACTOR; CYCLOOXYGENASE 2; EMBRYO, MAMMALIAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICROGLIA; MOTOR NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43149120225     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21620     Document Type: Article

References (62)

1. Albrecht PJ, Dahl JP, Stoltzfus OK, Levenson R, Levison SW. 2002. Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp Neurol 173:46-62.
2. Albrecht PJ, Murtie JC, Ness JK, Redwine JM, Enterline JR, Armstrong RC, Levison SW. 2003. Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production. Neurobiol Dis 13:89-101.
3. Albrecht PJ, Enterline JC, Cromer J, Levison SW. 2007. CNTF-activated astrocytes release a soluble trophic activity for oligodendrocyte progenitors. Neurochem Res 32:263-271.
4. Almer G, Guegan C, Teismann P, Naini A, Rosoklija G, Hays AP, Chen C, Przedborski S. 2001. Increased expression of the proinflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 49:176-185.
5. Aloisi F, Ria F, Adorini L. 2000. Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today 21:141-147.
6. Arakawa Y, Sendtner M, Thoenen H. 1990. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines. J Neurosci 10:3507-3515.
7. Araujo DM, Cotman CW. 1992. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in semle plaques in Alzheimer's disease. Brain Res 569:141-145.
8. Bandtlow CE, Meyer M, Lindholm D, Spranger M, Heumann R, Thoenen H. 1990. Regional and cellular codistribution of interleukin 1 beta and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J Cell Biol 111:1701-1711.
9. Basu A, Krady JK, Enterline JR, Levison SW. 2002a. Transforming growth factor beta1 prevents IL-1beta-induced microglial activation, whereas TNFalpha- and IL-6-stimulated activation are not antagonized. Glia 40:109-120.
10. Basu A, Krady JK, O'Malley M, Styren SD, DeKosky ST, Levison SW. 2002b. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J Neurosci 22:6071-6082.
11. Basu A, Lazovic J, Krady JK, Mauger DT, Rothstein RP, Smith MB, Levison SW. 2005. Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury. J Cereb Blood Flow Metab 25:17-29.
12. Benveniste EN. 1997. Role of macrophages/microgha in multiple sclerosis and experimental allergic encephalomyelitis [see comments]. J Mol Med 75:165-173.
13. Bohn MC. 2004. Motoneurons crave glial cell line-derived neurotrophic factor. Exp Neurol 190:263-275.
14. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, Mucke L. 1993. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A 90:10061-10065.
15. Carmel JB, Kakinohana O, Mestril R, Young W, Marsala M, Hart RP. 2004. Mediators of ischemic preconditioning identified by microarray analysis of rat spinal cord. Exp Neurol 185:81-96.
16. Dale SM, Kuang RZ, Wei X, Varon S. 1995. Corticospinal motor neurons in the adult rat: degeneration after intracortical axotomy and protection by ciliary neurotrophic factor (CNTF). Exp Neurol 135:67-73.
17. Davis S, Aldrich TH, Valenzuela DM, Wong VV, Furth ME, Squinto SP, Yancopoulos GD. 1991. The receptor for ciliary neurotrophic factor. Science 253:59-63.
18. Delgado M, Jonakait GM, Ganea D. 2002. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia. Glia 39:148-161.
19. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A. 1987. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol 17:1271-1278.
20. Ghezzi P, Mennini T. 2001. Tumor necrosis factor and motoneuronal degeneration: an open problem. Neuroimmunomodulation 9:178-182.
21. Giess R, Maurer M, Linker R, Gold R, Warmuth-Metz M, Toyka KV, Sendtner M, Rieckmann P. 2002. Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. Arch Neurol 59:407-409.
22. Gonzalez-Scarano F, Baltuch G. 1999. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22:219-240.
23. Hagg T, Varon S. 1993. Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc Natl Acad Sci U S A 90:6315-6319.
24. Hagg T, Varon S, Louis JC. 1993. Ciliary neurotrophic factor (CNTF) promotes low-affinity nerve growth factor receptor and CD4 expression by rat CNS microglia. J Neuroimmunol 48:177-187.
25. Henderson CE, Bloch-Gallego E, Camu W. 1994. Purified embryonic motoneurons. In: Cohen, Wilkin, editors. Neural cell culture: a practical approach. London: Oxford University Press.
26. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH. 1997. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A 94:1500-1505.
27. Hofman FM, Hinton DR, Johnson K, Merrill JE. 1989. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612.
28. Kahn MA, Ellison JA, Speight GJ, de Vellis J. 1995. CNTF regulation of astrogliosis and the activation of microglia in the developing rat central nervous system. Brain Res 685:55-67.
29. Klein MA, Moller JC, Jones LL, Bluethmann H, Kreutzberg GW, Raivich G. 1997. Impaired neuroglial activation in interleukin-6 deficient mice. Glia 19:227-233.
30. Klivenyi P, Kiaei M, Gardian G, Calingasan NY, Beal MF. 2004. Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 88:576-582.
31. Koistinaho J, Chan PH. 2000. Spreading depression-induced cyclooxygenase-2 expression in the cortex. Neurochem Res 25:645-651.
32. Krady JK, Basu A, Levison SW, Milner RJ. 2002. Differential expression of protein tyrosine kinase genes during microglial activation. Glia 40:11-24.
33. Lee GA, Lin CH, Jiang HH, Chao HJ, Wu CL, Hsueh CM. 2004. Microglia-derived glial cell line-derived neurotrophic factor could protect Sprague-Dawley rat astrocyte from in vitro ischemia-induced damage. Neurosci Lett 356:111-114.
34. Lenschow DJ, Herold KC, Rhee L, Patel B, Koons A, Qin HY, Fuchs E, Singh B, Thompson CB, Bluestone JA. 1996. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5:285-293.
35. Levison SW, McCarthy KD. 1991. Astroglia in culture. In: Banker GA, Goslin K, editors. Culturing nerve cells,1st ed. Cambridge, MA: MIT Press. p 309-336.
36. Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R. 2002. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 8:620-624.
37. Lipsky PE. 1999. The clinical potential of cyclooxygenase-2-specific inhibitors. Am J Med 106:51S-57S.
38. Lo AC, Li L, Oppenheim RW, Prevette D, Houenou LJ. 1995. Ciliary neurotrophic factor promotes the survival of spinal sensory neurons following axotomy but not during the period of programmed cell death. Exp Neurol 134:49-55.
39. Lowe J, MacLennan KA, Powe DG, Pound JD, Palmer JB. 1989. Microglial cells in human brain have phenotypic characteristics related to possible function as dendritic antigen presenting cells. J Pathol 159:143-149.
40. Lu YZ, Lin CH, Cheng FC, Hsueh CM. 2005. Molecular mechanisms responsible for microglia-derived protection of Sprague-Dawley rat brain cells during in vitro ischemia. Neurosci Lett 373:159-164.
41. MacLennan AJ, Vinson EN, Marks L, McLaurin DL, Pfeifer M, Lee N. 1996. Immunohistochemical localization of ciliary neurotrophic factor receptor alpha expression in the rat nervous system. J Neurosci 16:621-630.
42. Martin A, Hofmann HD, Kirsch M. 2003. Glial reactivity in ciliary neurotrophic factor-deficient mice after optic nerve lesion. J Neurosci 23:5416-5424.
43. Minghetti L, Walsh DT, Levi G, Perry VH. 1999. In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines. J Neuropathol Exp Neurol 58:1184-1191.
44. Monville C, Coulpier M, Conti L, De-Fraja C, Dreyfus P, Fages C, Riche D, Tardy M, Cattaneo E, Peschanski M. 2001. Ciliary neurotrophic factor may activate mature astrocytes via binding with the leukemia inhibitory factor receptor. Mol Cell Neurosci 17:373-384.
45. Penkowa M, Moos T, Carrasco J, Hadberg H, Molinero A, Bluethmann H, Hidalgo J. 1999. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 25:343-357.
46. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
47. Powell MB, Mitchell D, Lederman J, Buckmeier J, Zamvil SS, Graham M, Ruddle NH, Steinman L. 1990. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol 2:539-544.
48. Rose JW, Hill KE, Watt HE, Carlson NG. 2004. Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion. J Neuroimmunol 149:40-49.
49. Rosell DR, Nacher J, Akama KT, McEwen BS. 2003. Spatiotemporal distribution of gp130 cytokines and their receptors after status epilepticus: comparison with neuronal degeneration and microglial activation. Neuroscience 122:329-348.
50. Schaar DG, Sieber BA, Sherwood AC, Dean D, Mendoza G, Ramakrishnan L, Dreyfus CF, Black IB. 1994. Multiple astrocyte transcripts encode nigral trophic factors in rat and human. Exp Neurol 130:387-393.
51. Schwartz M, Butovsky O, Bruck W, Hanisch UK. 2006. Microglial phenotype: is the commitment reversible? Trends Neurosci 29:68-74.
52. Selmaj KW, Raine CS. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346.
53. Selmaj K, Raine CS, Cannella B, Brosnan CF. 1991. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87:949-954.
54. Sendtner M, Kreutzberg GW, Thoenen H. 1990. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345:440-441.
55. Sendtner M, Schmalbruch H, Stockli KA, Carroll P, Kreutzberg GW, Thoenen H. 1992. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy [see comments]. Nature 358:502-504.
56. Smith WL, DeWitt DL, Garavito RM. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69:145-182.
57. Streit WJ, Kreutzberg GW. 1988. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 268:248-263.
58. Streit WJ, Graeber MB, Kreutzberg GW. 1989. Expression of Ia antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury. Exp Neurol 105:115-126.
59. Streit WJ, Hurley SD, McGraw TS, Semple-Rowland SL. 2000. Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukin-6 in neuron-glia signaling during regeneration. J Neurosci Res 61:10-20.
60. Wang LJ, Lu YY, Muramatsu S, Ikeguchi K, Fujimoto K, Okada T, Mizukami H, Matsushita T, Hanazono Y, Kume A, Nagatsu T, Ozawa K, Nakano I. 2002. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci 22:6920-6928.
61. Yasojima K, Tourtellotte WW, McGeer EG, McGeer PL. 2001. Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy. Neurology 57:952-956.
62. Yin QW, Johnson J, Prevette D, Oppenheim RW. 1994. Cell death of spinal motoneurons in the chick embryo following deafferentation: rescue effects of tissue extracts, soluble proteins, and neurotrophic agents. J Neurosci 14:7629-7640.